Chemicals & Specialty Chemicals

A commodity chemical is defined by a specification anyone can meet. Caustic soda, soda ash, phenol, acetic acid — the buyer checks purity, compares landed price, and buys. Because the product is identical across suppliers, the price is set outside the company, by global capacity, freight and feedstock. The producer's only levers are cost and scale.

A specialty chemical is defined by what it does in the customer's product, not by what it is. A dye that has to hold a specific shade, an additive that has to keep a polymer stable at a given temperature, an intermediate that has to carry a specific impurity profile because the customer's downstream reaction is sensitive to it. The buyer is not comparing purity on a datasheet; they are buying a performance outcome they have already validated.

Above that sit custom synthesis and contract manufacturing. Here the customer owns the molecule and the intellectual property; the chemical company owns the process and the plant. A global agrochemical or pharmaceutical innovator hands over a route, and the Indian partner develops, scales and manufactures it. Contract development and manufacturing organisations (CDMOs) are the industrial-scale version of the same relationship. PI Industries is a well-known custom synthesis business for global agrochemical innovators; Tata Chemicals' soda ash operation sits at the opposite end as classic inorganic commodity chemistry.

The four rows below differ in one decisive way: who has the power to set the price. Everything else — margin stability, order-book visibility, the multiple the market pays — follows from that.

This is the part that is genuinely different from most sectors, and it is worth slowing down for. When a specialty chemical goes into a regulated end product — an agrochemical formulation, a pharmaceutical, an electronic component — the customer does not simply buy on spec. They run a qualification: audit the plant, test batches, run stability and performance studies, and then name that supplier and often that specific site in their own product registration with their own regulator.

Once that is done, changing supplier is not a purchasing decision. It is a re-qualification project: new trials, new stability data, sometimes a regulatory filing amendment, and the risk that the customer's own finished product behaves differently. Depending on the end market, that takes months to years. So the incumbent supplier keeps the business through ordinary price competition in a way a commodity producer never can. That is why order books at the top of the ladder are visible for years while a commodity producer effectively re-sells its capacity every quarter.

The same wall works in both directions, and readers usually only see one side of it. Qualification takes as long to win as it takes to lose. A company that has just built a new block has spent the capital but has no qualified customers on it yet, and it will carry depreciation and interest through the qualification period. A stretched validation timeline is one of the most common reasons a chemicals capex cycle disappoints on schedule.

Chemicals contracts fall into two families, and which one a company sells under matters more than most readers expect. In a pass-through contract, the selling price is indexed to a named input, so when the feedstock rises the price rises with it. The company's absolute profit per kilogram is protected; only the revenue number moves. In a fixed-price contract, the company has quoted a price for a period, so any rise in the input eats directly into the margin — and equally, a fall in the input widens it.

The practical consequence is a reading rule. In a pass-through business, revenue falling because feedstock prices fell is not a demand problem, and revenue rising because feedstock prices rose is not growth. You have to read volumes, and you have to read gross profit per kilogram, because those are the numbers that strip out the pass-through. Companies at the top of the ladder increasingly disclose volume growth separately for exactly this reason.

The same rule protects you from a common misdiagnosis in the other direction. A commodity producer's margin can widen sharply just because the feedstock fell faster than its realisation did — an inventory and lag effect, not an improvement in the business. When it reverses, so does the margin.

Most organic chemistry in India traces back to crude oil derivatives. Benzene, toluene, xylene and propylene are the workhorse building blocks, and they are refinery and cracker products, so their prices move with crude and with refining economics. When crude moves, the input cost of a very large part of the sector moves with it — with a lag, and with different effects depending on where the company sits on the ladder.

The direction is not uniform, which is why 'crude fell, chemicals will do well' is too crude a rule. A commodity producer's realisation is itself indexed to the feedstock, so a falling input drags its selling price down too. A fixed-price specialty maker genuinely benefits in the short run, because it keeps the difference until the next contract reset. A pass-through business is largely neutral on margin and simply reports lower revenue.

Not everything is crude-linked. Inorganic chemistry — caustic soda, soda ash, chlor-alkali — runs on salt, limestone and above all electricity, so its cost curve is a power tariff story rather than an oil story. Fluorochemistry runs on fluorspar. Knowing which feedstock a company actually consumes stops you applying the wrong macro input to it. Freight and energy costs sit on top of both, and for exporters they can move the landed-cost comparison enough to change competitiveness on their own.

A capacity announcement is not revenue, and the gap between the two is longer in chemicals than in almost any other manufacturing sector. Understanding the sequence tells you where in the cycle a company actually is, and it explains why return on capital falls before it rises.

There is no such thing as 'the chemicals cycle' in India. The sector supplies end markets that have nothing to do with each other and that turn at different times, for different reasons. A chemicals index moving up tells you some of these cycles turned; it does not tell you which, and the ones that matter for a given company may be the ones that did not.

Environmental compliance in chemicals is not a footnote. Consent to operate, effluent treatment, zero liquid discharge where mandated, hazardous waste handling, emission monitoring and periodic inspection all carry both capital cost and a running cost per tonne. A serious incident or a violation order can shut a plant, and a shutdown in a continuous process is expensive well beyond the days lost.

The same cost is also a moat, and this is the part worth understanding properly. Permits for new capacity in polluting chemistries are slow and sometimes simply unavailable in a given cluster. That limits new competition in a way no patent does. It is one of the structural reasons that when China tightened environmental enforcement across its chemical clusters, capacity in several chemistries moved and Indian producers picked it up. A high compliance bar is bad for the newcomer and good for the incumbent who already cleared it.

Exporters carry a second layer. Selling into Europe requires registration under REACH — Registration, Evaluation, Authorisation and Restriction of Chemicals — which costs money and time per substance. That is another fixed cost that favours scale, and another reason a small producer cannot simply decide to serve a regulated market next quarter.

'Specialty chemicals' is a marketing phrase as much as a technical one, and plenty of companies that use it are selling standard product into a competitive market. This matters because the market pays a very different multiple for the two, so a misclassification is expensive in both directions — you can overpay for a commodity producer wearing the label, or overlook a genuine specialty business inside a company with a dull name.

You do not need industry contacts to check this. The disclosures give it away, because a commodity business cannot hide the fingerprint of a price it does not set. Run the checklist below against the last eight to twelve quarters. If realisation per kilogram tracks a published commodity price and gross margin swings with the feedstock, you are looking at commodity economics whatever the presentation says. If realisation is stable through feedstock moves and the customer list is short and long-standing, the specialty claim is doing real work.